Integrating Co-treatment in Tobacco Cessation: Tobacco and Behavioral Health Masterclass
Original Air Date: Thursday, March 18, 1-3:30 pm ET
Although individuals with mental illnesses and substance use disorders account for 40% of adults who use tobacco, tobacco treatment is often overlooked in addiction treatment settings. However, studies have shown that individuals who receive treatment to address tobacco use simultaneously with other substance use have a 25% greater chance to sustain their recovery.
In the Tobacco and Behavioral Health Workshop, University of Colorado-Anschutz Medical Campus subject matter experts Chad Morris, PhD, director, Behavioral Health and Wellness Program, and Jim Pavlik, MA, senior program and policy analyst, Behavioral Health and Wellness Program, will equip you with:
• Tools to understand the importance of co-treatment in tobacco cessation to support long-term recovery.
• Practical guidance to outline pathways for incorporating co-treatment into existing clinical workflows.
• Knowledge of strategies to maximize effectiveness of co-treatment in mental health and addiction treatment facilities.
You’ll leave with a greater understanding of the prevalence of nicotine dependency in mental health and addiction treatment settings as we discuss the clinical workflow and policy implications for concurrently addressing the tobacco and opioid epidemics, address barriers and develop realistic clinical and health system change goals for co-treatment of nicotine dependency and other addictions.
This event is co-hosted by UCSF’s Smoking Cessation Leadership Center and the National Behavioral Health Network for Tobacco and Cancer Control, supported by the Centers for Disease Control and Prevention.
- Download presentation slides
- Download syllabus
- Download CE/CME disclosures and information
- Download speaker bios
- Access closed captioning
- Archived recording
- Morris CD, Garver-Apgar CE. Nicotine and Opioids: a Call for Co-treatment as the Standard of Care. J Behav Health Serv Res. 2020 Oct;47(4):601-613. doi: 10.1007/s11414-020-09712-6. PMID: 32495248; PMCID: PMC7269614.